Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Pheon Therapeutics is a leading Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide range of hard-to-treat cancers.Pheon is utilizing its expertise, know-how and access to wholly owned, proprietary antibodies and payloads to develop a pipeline of solid tumor-targeting ADCs with the aim of treating cancers with significant unmet need.

List your booth number for exhibitions, ask us